Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome
Status:
Recruiting
Trial end date:
2022-04-16
Target enrollment:
Participant gender:
Summary
The main objective of the study is to assess the feasibility, safety, and tolerability of the
administration of HCR040, a drug whose active substance is HC016, allogeneic adipose-derived
adult mesenchymal stem cells expanded and pulsed with H2O2, in patients with acute
respiratory distress syndrome.